Jivi
Payments companies reported to CMS as associated with Jivi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Jivi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Jivi
These are the largest totals companies reported as associated with Jivi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Leslie Soto Velez | San Juan, PR | Pediatrics | $41,463.46 |
| Kim Schafer | Sacramento, CA | Family | $14,090.94 |
| Vanessa Salinas-Luna | Orange, CA | Pediatric Hematology-Oncology | $13,434.58 |
| Shveta Gupta | Orlando, FL | Pediatric Hematology-Oncology | $8,254.42 |
| Mark Reding | Minneapolis, MN | Hematology & Oncology | $4,264.39 |
| Akshat Jain | Redlands, CA | Pediatric Hematology-Oncology | $3,699.91 |
| Shayla Bergmann | Beaufort, SC | Pediatric Hematology-Oncology | $2,406.14 |
| Amanda Blair | Winston Salem, NC | Pediatric Hematology-Oncology | $2,406.14 |
| Maissaa Janbain | New Orleans, LA | Hematology & Oncology | $2,403.00 |
| Doris Quon | Los Angeles, CA | Hematology (Internal Medicine) | $2,179.51 |
Prescribed Jivi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.